Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1536
  • Embargo expired:
    21-Oct-2018 6:00 AM EDT

Article ID: 700835

NOW AVAILABLE: Abstracts to be presented at the American Neurological Association’s 143rd Annual Meeting October 21-23, 2018

American Neurological Association (ANA)

Embargoed abstracts to be presented at the American Neurological Association’s 143rd Annual Meeting October 21-23, 2018 at the Hyatt Regency Atlanta are now available to journalists upon request.

Released:
21-Sep-2018 9:00 AM EDT
  • Embargo expired:
    21-Oct-2018 12:00 AM EDT

Article ID: 700198

American Neurological Association highlights abstracts to be presented at the 143rd Annual Meeting October 21-23, 2018 in Atlanta

American Neurological Association (ANA)

Methods to more precisely inject stem cells into the spinal cord; an enzyme that enhances the synthesis of dopamine in people with Parkinson’s disease; a drug that protects against chemotherapy-induced neuropathy – these are just a few of the exciting research findings that will be presented at the American Neurological Association’s 143rd Annual Meeting October 21-23, 2018 at the Hyatt Regency Atlanta.

Released:
12-Sep-2018 9:00 AM EDT
wvumedicine.jpg

Article ID: 702388

West Virginia University Rockefeller Neuroscience Institute Pioneers Promising New Alzheimer’s Therapy

West Virginia University

Investigators at the West Virginia University Rockefeller Neuroscience Institute performed the first procedure in the world of a phase II trial using focused ultrasound to treat a patient with early stage Alzheimer’s.

Released:
17-Oct-2018 3:30 PM EDT
Brain_Imaging_Scan_iStock-136191759.jpg

Article ID: 702315

Deep Brain Stimulation for Alzheimer’s Not for Everyone

Johns Hopkins Medicine

In a report of the phase II ADvance clinical trial, Johns Hopkins researchers report that people diagnosed under age 65—those with early-onset Alzheimer’s disease—didn’t benefit from deep brain stimulation. Their findings appeared in the July issue of the Journal of Alzheimer’s Disease.

Released:
17-Oct-2018 8:00 AM EDT

Article ID: 702160

Experts Recommend New Way to Describe Cognitive Changes After Anesthesia and Surgery in Elderly Patients

American Society of Anesthesiologists (ASA)

A multidisciplinary, international group of experts has recommended changing the way clinicians and patients describe cognitive changes experienced in some patients after anesthesia and surgery. The recommendations are being published simultaneously in six peer-reviewed journals including, Anesthesiology.

Released:
16-Oct-2018 9:00 AM EDT

Article ID: 702242

Long-Running Study Identifies Modifiable Dementia Risk Factor in Older Adults

Health Sciences at the University of Pittsburgh

Stiffness of the aorta – more so than blood pressure or subclinical brain disease – is a key risk factor for dementia. Since aortic stiffness can be reduced by medication and healthy lifestyle changes, these results suggest that people can still lower their dementia risk well into old age.

Released:
16-Oct-2018 9:00 AM EDT

Article ID: 702256

MEDIA CALL-IN OPPORTUNITY: American Neurological Association faculty to present research highlights from the 143rd Annual Meeting Monday, October 22

American Neurological Association (ANA)

For the first time, the American Neurological Association’s 143rd Annual Meeting will feature a media roundtable on Monday, October 22, 2018 from 11:50-1:00 p.m. at which presenters of the six principal symposia will present highlights, discuss the relevance of the work, and answer questions. To RSVP for the media roundtable and request dial-in information if you are not able to attend in person, please contact Rachel Brown at rbrown@steegethomson.com.

Released:
16-Oct-2018 9:00 AM EDT
Karyn.Frick.jpg

Article ID: 702065

‘Stripped down’ estrogen holds promise for treating dementia in women

University of Wisconsin-Milwaukee

Researchers from three Milwaukee-area universities have developed a “stripped-down” estrogen molecule that improves memory in an animal model of post-menopausal dementia, kickstarting new drug discovery for treating memory loss in women.

Released:
11-Oct-2018 1:05 PM EDT
  • Embargo expired:
    10-Oct-2018 4:00 PM EDT

Article ID: 701690

Have an Irregular Heartbeat? You May Have an Increased Risk of Dementia

American Academy of Neurology (AAN)

People with a particular kind of irregular heartbeat called atrial fibrillation may experience a faster decline in thinking and memory skills and have a greater risk of dementia than those without atrial fibrillation, according to a study published in the October 10, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Released:
4-Oct-2018 3:05 PM EDT
  • Embargo expired:
    8-Oct-2018 11:00 AM EDT

Article ID: 701557

Previously unknown genetic aberrations found to be associated with Alzheimer’s progression

Mount Sinai Health System

Researchers present comprehensive genome-wide map of RNA splicing variation in aging brain – novel insights could offer new strategies for diagnosis and treatment of Alzheimer’s disease

Released:
3-Oct-2018 12:05 PM EDT

Showing results

110 of 1536

Chat now!